1. Home
  2. DMRA vs UPBD Comparison

DMRA vs UPBD Comparison

Compare DMRA & UPBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Damora Therapeutics Inc. Common Stock

DMRA

Damora Therapeutics Inc. Common Stock

SELL

Current Price

$22.10

Market Cap

1.4B

Sector

Health Care

ML Signal

SELL

Logo Upbound Group Inc.

UPBD

Upbound Group Inc.

SELL

Current Price

$24.49

Market Cap

1.1B

ML Signal

SELL

Company Overview

Basic Information
Metric
DMRA
UPBD
Founded
2011
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Diversified Commercial Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.1B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
DMRA
UPBD
Price
$22.10
$24.49
Analyst Decision
Strong Buy
Buy
Analyst Count
10
6
Target Price
★ $46.78
$27.33
AVG Volume (30 Days)
478.7K
★ 1.4M
Earning Date
11-04-2026
10-29-2026
Dividend Yield
N/A
★ 6.26%
EPS Growth
★ 121.48
N/A
EPS
N/A
★ 1.56
Revenue
N/A
★ $4,695,061,000.00
Revenue This Year
N/A
$0.34
Revenue Next Year
N/A
$3.31
P/E Ratio
★ N/A
$15.98
Revenue Growth
N/A
★ 8.67
52 Week Low
$16.50
$14.98
52 Week High
$34.89
$25.52

Technical Indicators

Market Signals
Indicator
DMRA
UPBD
Relative Strength Index (RSI) 49.17 69.69
Support Level $18.03 $17.74
Resistance Level $22.27 N/A
Average True Range (ATR) 1.83 1.29
MACD 0.03 0.17
Stochastic Oscillator 30.13 87.52

Price Performance

Historical Comparison
DMRA
UPBD

About DMRA Damora Therapeutics Inc. Common Stock

Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.

About UPBD Upbound Group Inc.

Upbound Group Inc is an omnichannel platform company committed to elevating financial opportunity for all through inclusive, and technology-driven financial solutions that address the evolving needs and aspirations of consumers. It has four operating segments; The Rent-A-Center Business segment operates lease-to-own stores, the Acima segment offers the lease-to-own transaction to consumers who do not qualify for financing from the traditional retailer, and also offers the lease-to-own transaction through virtual offering solutions, Mexico segment offers lease-to-own stores in Mexico. The The Brigit segment offers various financial health products and tools to help users improve their financial health. The company derives a majority of its revenue from the Acima segment.

Share on Social Networks: